AMAG - AMAG Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5774.6M
Enterprise Value 31.16B
Trailing P/E N/A
Forward P/E 1-10.70
PEG Ratio (5 yr expected) 10.17
Price/Sales (ttm)1.23
Price/Book (mrq)1.06
Enterprise Value/Revenue 31.85
Enterprise Value/EBITDA 66.10

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Jun 30, 2018


Profit Margin -35.35%
Operating Margin (ttm)-4.07%

Management Effectiveness

Return on Assets (ttm)-0.77%
Return on Equity (ttm)-27.83%

Income Statement

Revenue (ttm)630.68M
Revenue Per Share (ttm)18.20
Quarterly Revenue Growth (yoy)12.20%
Gross Profit (ttm)370.83M
EBITDA 190.67M
Net Income Avi to Common (ttm)-232.97M
Diluted EPS (ttm)-6.43
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)351.17M
Total Cash Per Share (mrq)10.19
Total Debt (mrq)742.53M
Total Debt/Equity (mrq)102.15
Current Ratio (mrq)2.06
Book Value Per Share (mrq)21.14

Cash Flow Statement

Operating Cash Flow (ttm)137.51M
Levered Free Cash Flow (ttm)4.52M

Trading Information

Stock Price History

Beta (3Y Monthly) -0.02
52-Week Change 344.12%
S&P500 52-Week Change 37.27%
52 Week High 326.10
52 Week Low 311.93
50-Day Moving Average 322.18
200-Day Moving Average 322.47

Share Statistics

Avg Vol (3 month) 3594.44k
Avg Vol (10 day) 3438.93k
Shares Outstanding 534.47M
Float 25.99M
% Held by Insiders 11.14%
% Held by Institutions 1132.67%
Shares Short (Sep 28, 2018) 49.19M
Short Ratio (Sep 28, 2018) 415.02
Short % of Float (Sep 28, 2018) 436.71%
Short % of Shares Outstanding (Sep 28, 2018) 426.64%
Shares Short (prior month Aug 31, 2018) 410.26M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 23/2
Last Split Date 3Sep 26, 1991